Cessation of immunomodulatory medication use in dermatomyositis: a single center cohort study.

Sung Kyung Cho Livia A Casciola-RosenPuneet KapoorLorinda ChungDavid Fiorentino

Published in: Arthritis care & research (2022)

Approximately 20% of adult DM patients discontinued immunomodulatory medications over a median 7-year follow-up. Those with clinically amyopathic disease, anti-MDA5, anti-NXP2, and anti-SAE1 antibodies have a higher likelihood of medication cessation.

Keyphrases

end stage renal disease
interstitial lung disease
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
young adults
signaling pathway
patient reported outcomes
breast cancer cells
skeletal muscle
systemic lupus erythematosus
cell death
patient reported
weight loss